Renal Cancer - Results from #5400

Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study January 15, 2017

Inflammatory Myofibroblastic Tumor of the Kidney: A Rare Renal Tumor January 13, 2017

Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma January 13, 2017

Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients January 12, 2017

Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects January 12, 2017

The association between age-related macular degeneration and renal cell carcinoma: a nested case-control study January 12, 2017

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma January 11, 2017

Functional significance of CD105-positive cells in papillary renal cell carcinoma January 11, 2017

Sorafenib versus sunitinib as first-line treatment agents in Chinese patients with metastatic renal cell carcinoma: the largest multicenter retrospective analysis of survival and prognostic factors January 11, 2017

SU-D-207A-07: The Effects of Inter-Cycle Respiratory Motion Variation On Dose Accumulation in Single Fraction MR-Guided SBRT Treatment of Renal Cell Carcinoma January 11, 2017

Biological Features of a Renal Cell Carcinoma Cell Line Derived from Spinal Metastasis January 11, 2017

A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma January 11, 2017

A Randomized Phase 2 Study of MK-2206 versus Everolimus in Refractory Renal Cell Carcinoma January 11, 2017

SU-F-R-39: Effects of Radiation Dose Reduction On Renal Cell Carcinoma Discrimination Using Multi-Phasic CT Imaging January 11, 2017

3D printed renal cancer models derived from MRI data: application in pre-surgical planning January 9, 2017

Mixed Results for Sunitinib in Renal Cancer January 9, 2017

Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma January 9, 2017

Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma. January 9, 2017

How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma January 9, 2017

Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma January 9, 2017

Page 271 of 456